glp 1 incretin Targeting both receptors together for a new generation of diabetes therapies The incretin system: glucagon-like peptide-1

Taketa T, Xiao L, Sudo K, Suzuki A, Wadhwa R, Blum MA, Lee JH, Weston B, Bhutani MS, Skinner H, Komaki R, Maru DM, Rice DC, Swisher SG , Hofstetter WL, Ajani JA

MAM3 catalyzes the formation of all aliphatic glucosinolate chain lengths in Arabidopsis

In each case, the honest framing is that the evidence is preliminary, the combination is investigational , and robust human clinical trial data specific to these uses are limited

Strohman, M

Collectively, these findings suggest that Epitalon may not function as a traditional sleep aid but rather as an influence on the biological systems that regulate sleep timing and circadian organization